Afya Ltd

Afya Ltd. is a medical education group, which engages in the provision of an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners through their medical residency preparation, post-graduate programs, and continuing medical education activities. It operates through Education Services; and Digital Content, Residency Preparatory and Specialization Programs segments. The Education Services segment provides educational services through undergraduate and graduate courses related to medicine, other health sciences, and other undergraduate programs. The Residency Preparatory and Specialization Programs segment offers digital and printed medical content services, including online courses for residency preparatory, medical and other than medical post-graduate specialization programs and mobile app subscription for digital medical content. The company was founded on March 22, 2019 and is headquartered in Nova Lima, Brazil.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Afya Ltd excels in Q2 2024 earnings, eyes growth opportunities

Afya Ltd delivered a robust performance in Q2 2024, marked by significant growth in key financial metrics, student base expansion, and strategic acquisitions.
The company's strengths lie in its strong financial position, updated guidance, operational insights, and engagement with analysts on critical industry topics.
Challenges include maintaining margins, integrating acquisitions, managing growth effectively, and adapting to potential regulatory shifts in the sector.
Opportunities for Afya include leveraging growth trends, strategic partnerships, innovation, and operational excellence to drive sustainable value creation and market leadership.

Afya Ltd reports strong Q3 earnings and eyes sustainable growth

Afya Ltd delivered a robust performance in Q3 2024, with notable revenue and EBITDA growth, demonstrating operational efficiency and financial resilience.
Despite facing challenges in a competitive landscape, the company's strategic acquisitions and focus on operational metrics provide a solid foundation for future growth.
With a strong balance sheet, improved margins, and a focus on sustainable expansion, Afya Ltd is well-positioned to capitalize on opportunities in the healthcare education sector.
Investors should monitor Afya Ltd's execution of growth strategies, operational performance, and ability to navigate challenges to assess its long-term value creation potential.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The average of price targets set by Wall Street analysts indicates a potential upside of 25% in Afya (AFYA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Wall Street Analysts Think Afya (AFYA) Could Surge 25.03%: Read This Before Placing a Bet

Afya gains surprise regulatory approval to expand its medical seats. The incremental valuation gain, along with the strong revenue momentum points to a good Q4/FY22 result ahead.

Afya: On Track For More Seat Expansion As The Growth Story Continues

NOVA LIMA, Brazil--( BUSINESS WIRE )--Afya Limited, or Afya (Nasdaq: AFYA), in addition to the Press Release released by the Company on October 13, 2022, today announced the closing of its acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Sociedade Educacional e Cultural Sergipe DelRey Ltda. (“DelRey”), that encompasses the operations of Centro Universitário Tiradentes Alagoas (“UNIT Alagoas”) and Faculdade Tiradentes Jaboatão dos Guararapes (“FITS Jaboatão dos Guararapes”). The transaction does not enclose the “UNIT” and “FITS” brands, which will be licensed for Afya during the first year of operation.

Afya Limited Announces Closing of the Acquisition of UNIT Alagoas and FITS Jaboatão dos Guararapes

Here is how Afya (AFYA) and WillScot (WSC) have performed compared to their sector so far this year.

Is Afya (AFYA) Outperforming Other Consumer Discretionary Stocks This Year?

NOVA LIMA, Brazil--( BUSINESS WIRE )--Afya Limited or Afya (Nasdaq: AFYA) today announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (“MEC”) authorized the increase of 64 medical seats of Faculdade Santo Agostinho, in the city of Itabuna, located in the state of Bahia.

Afya Limited Announces Medical Seats Increase in FASA Itabuna

NOVA LIMA, Brazil--( BUSINESS WIRE )--Afya Limited, or Afya (Nasdaq: AFYA) today announced the closing of the issuance, through its wholly-owned subsidiary Afya Participações S.A., of 500,000 simple, non-convertible, unsecured debentures in a single series, each with a par value of R$1,000, totaling an aggregate amount of R$500 million (“Debentures”), by means of a public distribution with restricted placement efforts in the Brazilian market (the “Offering”), under the terms of the Brazilian Securities and Exchange Commission (“CVM”) Rule No. 476, dated January 16, 2009, and was not generally made anywhere outside of Brazil, including in the United States or to US investors. Accordingly, the Debentures were not and will not be registered under the United States Securities Act of 1933, as amended (the “Securities Act”) and may not be offered or sold in the United States absent registration or an applicable exemption from registration under the Securities Act.

Afya Limited Announces Closing of Debentures Issuance in Brazilian Market

NOVA LIMA, Brazil--( BUSINESS WIRE )--Afya Limited, or Afya (Nasdaq: AFYA), today announced that Mr. Flávio Dias, a board member since July 2020, has ended his term as an independent member of the Board of Directors, and will not be renewed. The remaining independent board members will have their term extended until Afya's next Annual General Meeting. Furthermore, Afya also announced that Mr. Daulins Emilio, a board member since August 2019, has submitted his resignation letter as a member of the Board of Directors and, consequently, Bertelsmann SE&Co. KGaA has appointed Mrs. Tina Krebs as his replacement, effective as of today. With these changes, the number of women members now represents 40% of the Board of Directors.

Afya Announces Changes to its Board of Directors and increase in women's representation

NOVA LIMA, Brazil--( BUSINESS WIRE )--Afya Limited, or Afya (Nasdaq: AFYA), today announced its intention to issue, through its wholly-owned subsidiary Afya Participações S.A., 500,000 simple, non-convertible, unsecured debentures in a single series, each with a par value of R$1,000, totaling an aggregate amount of R$500 million (“Debentures”), by means of a proposed public distribution with restricted placement efforts in the Brazilian market (the “Offering”), under the terms of the Brazilian Securities and Exchange Commission (“CVM”) Rule No. 476, dated January 16, 2009, and is not being generally made anywhere outside of Brazil, including in the United States or to US investors. Accordingly, the Debentures will not be registered under the United States Securities Act of 1933, as amended (the “Securities Act”) and may not be offered or sold in the United States absent registration or an applicable exemption from registration under the Securities Act.

Afya Limited Announces Intended Issuance of Debentures in Brazilian Market

Afya Limited (NASDAQ:AFYA ) Q3 2022 Earnings Conference Call November 21, 2022 5:00 PM ET Company Participants Ana Raquel Torres - IR Virgilio Gibbon - CEO Luis Andre Blanco - CFO Conference Call Participants Luca Marcussini - Itau Frederico Mendes - Bank of America Merrill Lynch Marcelo Santos - JPMorgan Vitor Tomita - Goldman Sachs Mauricio Cepeda - Credit Suisse Ana Raquel Torres Thank you for joining us for Afya's Third Quarter 2022 Conference Call. Today, I'm here with Afya's CEO, Virgilio Gibbon and Luis Andre Blanco, our CFO.

Afya Limited (AFYA) Q3 2022 Earnings Call Transcript

Afya (AFYA) delivered earnings and revenue surprises of -7.69% and 3.72%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Afya (AFYA) Q3 Earnings and Revenues Miss Estimates

NOVA LIMA, Brazil--( BUSINESS WIRE )--Afya Limited (Nasdaq: AFYA) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the three and nine-month period ended September 30, 2022 (third quarter 2022). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).

Afya Limited Announces Third-Quarter and Nine Months 2022 Financial Results

Medical education stock Afya nears a buy point as analysts project strong EPS growth. The company entered into a purchase agreement to expand into the Brazilian Northeast.

Medical Education Stock Sees Strong EPS Growth; Nears Buy Point

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited, or Afya (Nasdaq: AFYA), today announced that it will report Third Quarter and Nine Months 2022 Financial Results for the period ended September 30, 2022, following the close of the market on Monday, November 21st, 2022 and will host a corresponding conference call and webcast at 05:00 pm ET.

Afya Limited to Report Third Quarter and Nine Months 2022 Financial Results on November 21st

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited, or Afya (Nasdaq: AFYA), announced today that it has entered into a share purchase agreement for the acquisition, through its wholly-owned subsidiary Afya Participações S.A.

Afya Limited Announces Entering Into a Share Purchase Agreement for the Acquisition of UNIT Alagoas and FITS Jaboatão dos Guararapes

Afya Limited (NASDAQ:AFYA ) Q2 2022 Earnings Conference Call August 22, 2022 5:00 PM ET Company Participants Ana Raquel Torres - Investor Relations Virgilio Gibbon - Chief Executive Officer Luis André Blanco - Chief Financial Officer Conference Call Participants Vinicius Figueiredo - Itau BBA Mauricio Cepeda - Credit Suisse Marcelo Santos - JPMorgan Yan Cesquim - BTG Pactual Ana Raquel Torres Thank you for joining us for Afya's Second Quarter 2022 Conference Call. Today I'm here with Afya's CEO, Virgilio Gibbon and Luis André Blanco, our CFO.

Afya Limited's (AFYA) CEO Virgilio Gibbon on Q2 2022 Results - Earnings Call Transcript

Afya (AFYA) delivered earnings and revenue surprises of 13.04% and 2.08%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Afya (AFYA) Beats Q2 Earnings and Revenue Estimates

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the three and six-month period ended June 30, 2022 (second quarter 2022). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Second Quarter 2022 Highlights 2Q22 Adjusted Net Revenue in

Afya Limited Announces Second-Quarter and First Half 2022 Financial Results

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited, or Afya (Nasdaq: AFYA), today announced that it will report Second-Quarter and First Half 2022 Financial Results for the period ended June 30, 2022, following the close of the market on Monday, August 22nd, 2022 and will host a corresponding conference call and webcast at 05:00 pm ET. A live and archived webcast of the call will be available on the Investor Relations section of the Company's website at https://ir.afya.com.br/. To participate in

Afya Limited to Report Second-Quarter and First Half 2022 Financial Results on August 22nd

The average of price targets set by Wall Street analysts indicates a potential upside of 76.2% in Afya (AFYA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Wall Street Analysts Believe Afya (AFYA) Could Rally 76%: Here's is How to Trade

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited or Afya (Nasdaq: AFYA) announces that it has released its 2021 Sustainability Report. The report highlights the Company's commitment and progress on environmental, social, and governance (ESG) initiatives. “This ecosystem, which combines education and technology, is unique to Afya and goes beyond the goal of merely boosting business activity; it also intensifies the positive impact we can have on society as a whole. By working with both education

Afya Limited Releases 2021 Sustainability Report

Afya Limited (NASDAQ:AFYA ) Q1 2022 Earnings Conference Call May 13, 2022 5:00 PM ET Company Participants Renata Couto - Director of IR Virgilio Gibbon - CEO Luis Blanco - CFO Conference Call Participants Mauricio Cepeda - Credit Suisse Victor Tomito - Goldman Sachs Vinicius Ribeiro - UBS Renata Couto Good evening, everyone. Thank you for joining us for Afya's First Quarter 2022 Conference Call.

Afya Limited (AFYA) CEO Virgilio Gibbon on Q1 2022 Results - Earnings Call Transcript

Afya (AFYA) delivered earnings and revenue surprises of 13.33% and 3.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Afya (AFYA) Q1 Earnings Beat Estimates

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited, or Afya (Nasdaq: AFYA) today announced the acquisition, through its wholly-owned subsidiary Afya Participações S.A, of 100% of Glic. Glic is a free diabetes care and management app solution for physicians and patients that uses technology to improve diabetes education and daily routine practices, connecting users, devices and health providers. Glic has more than 90.000 active end-users, and more than 1.100 physicians using the app. The company e

Afya Limited Announces the Acquisition of Glic

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the three-month period ended March 31, 2022 (first quarter 2022). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). First Quarter 2022 Highlights 1Q22 Adjusted Net Revenue increased 4

Afya Limited Announces First-Quarter 2022 Financial Results

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited, or Afya (Nasdaq: AFYA), further to the press releases issued by the Company on March 7, 2022 and April 25, 2022, today announced the closing of the transaction where Bertelsmann SE& Co. KGaA, or “Bertelsmann” acquired 6,000,000 Class B common shares of Afya at the purchase price of US$26.90 per share, from Nicolau Carvalho Esteves, Rosângela de Oliveira Tavares Esteves and NRE Capital Ventures Ltd (together with Nicolau Carvalho Esteves and

News for Afya Ltd Stock (AFYA)